Columbia and Alkeus University enter license contract for potential therapies for dry-AMD.

‘Human beings have evolved to utilize natural micronutrients or vitamin supplements that regulate a multitude of physiological features. By altering the chemical substance structure of these vitamins, we are able to regulate or improve the biological processes that they control potentially.’ Dr. Leonide Saad, Chief Executive Officer of Alkeus, described, ‘These supplement A aggregates accumulate in dry-AMD and, to an faster extent even, in Stargardt disease because of a genetic defect that exacerbates this process. Ilyas has shown elegantly, in a mouse model of Stargardt, that slightly changing vitamin A reduces the price of formation of these aggregates significantly, eventually preserving visual function.Physicians retiring early. Small procedures bankrupted by up-front expenses or locked into ineffective systems by the prohibitive cost of switching. Hours consumed by onerous data access unrelated to patient treatment. Workflow disruptions. And most importantly, massive intrusions on our patient relationships. These complaints could be dismissed as growing pains, born of resistance to improve. But transitional chaos must be distinguished from enduring damage. Nevertheless, the researchers found exceptional EHR-induced distress.